The phagocyte cytochrome LI -, a heterodimer comprised of gp9lPn0" and p22ph"". is a flavocytochrome that mediates the transfer of electrons from NADPH to molecular oxygen in the respiratory burst oxidase. The human gene encoding the glycosylated gp9lPhox subunit is the site of mutations in X-linked chronic granulomatous disease (CGD). Reverse transcriptase-polymerase chain reaction was used to obtain a full-length clone for the murine gp9lPnox cDNA, which was 87% identical to the human gp9lPhox cDNA. The encoded murine protein had 39 amino acids out of 570 that differed from the human, many of which were conservative substitutions. Nonconservative replacements occurred in hydrophilic regions outside of domains previously implicated in binding to NADPH, flavin, and the cytosolic oxidase subunit HE PHAGOCYTE respiratory burst oxidase (NADPH T oxidase) plays a central role in host defense, catalyzing the transfer of electrons from NADPH to molecular oxygen thereby generating the superoxide radical (0;). Superoxide is then converted into toxic oxygen derivatives that are essential for intact microbicidal function.' The oxidase is dormant in resting phagocytes but, upon cellular activation by inflammatory stimuli, is rapidly assembled at the plasma membrane from cytosolic and membrane components. An unusual b-type cytochrome, cytochrome is located in the plasma membrane, where it functions as the redox center of the oxidase. Cytochrome b558 is a heterodimer composed of two tightly associated polypeptides, gp91Ph" and ~22~"O', and is expressed almost exclusively in phagocytic leukocytes.'-' Two soluble oxidase subunits, p47p"Ox and ~67~"O", translocate to the membrane upon oxidase activation, along with a small guanosine triphosphatase, R~c .~.~ Mutations in any one of the four phox oxidase subunits result in chronic granulomatous disease (CGD), with defects in the X-linked gene for gp9lPh0" accounting for the majority of cases.' CGD phagocytes lack respiratory burst oxidase activity and exhibit impaired microbial killing, which leads to recurrent and frequently life-threatening bacterial and fungal infections.
T oxidase) plays a central role in host defense, catalyzing the transfer of electrons from NADPH to molecular oxygen thereby generating the superoxide radical (0;). Superoxide is then converted into toxic oxygen derivatives that are essential for intact microbicidal function.' The oxidase is dormant in resting phagocytes but, upon cellular activation by inflammatory stimuli, is rapidly assembled at the plasma membrane from cytosolic and membrane components. An unusual b-type cytochrome, cytochrome is located in the plasma membrane, where it functions as the redox center of the oxidase. Cytochrome b558 is a heterodimer composed of two tightly associated polypeptides, gp91Ph" and ~22~"O', and is expressed almost exclusively in phagocytic leukocytes.'-' Two soluble oxidase subunits, p47p"Ox and ~67~"O", translocate to the membrane upon oxidase activation, along with a small guanosine triphosphatase, R~c .~.~ Mutations in any one of the four phox oxidase subunits result in chronic granulomatous disease (CGD), with defects in the X-linked gene for gp9lPh0" accounting for the majority of cases.' CGD phagocytes lack respiratory burst oxidase activity and exhibit impaired microbial killing, which leads to recurrent and frequently life-threatening bacterial and fungal infections.
Cytochrome b558 is a flavocytochrome that contains two heme groups embedded within the plasma membrane as well as a flavin group that acts as the initial acceptor of electrons from
The specific functional domains of the cytochrome have been only partially characterized. At least one of the heme groups may be shared between the gp91Ph"x and ~2 2~~"~ subunits," whereas the flavin and NADPH binding sites appear to be localized in the carboxyl-terminal portion of gp91Ph"."~" In addition to their close functional relationship, interactions between gp91Ph" and appear important for normal intracellular processing and stability of each cytochrome subunit.','' For example, genetic deficiency in either gp9lPhoX or ~2 2~~~ results in markedly diminished levels of the unaffected subunit.19 Cytochrome b558 also acts as the focal point for assembly of the active oxidase complex. Translocation of cytosolic oxidase subunits upon cellular activation fails to occur in the absence of cytochrome b558.5.20,21 Multiple interactions between both cytochrome subunits and ~4 7 "~" appear to be important for normal assembly of the oxidase.1.z2.23 p47ph0x. Some substitutions altered potential N-glycosylation sites, which is likely to explain why the glycorylated murine protein migrates with an apparent molecular mass of 58 kD instead of 91 kD as seen for the human protein.
Expression of murine gp91-in a human myeloid cell line with a null gp9lPhox allele using a mammalian expression plasmid or a retroviral vector rescued stable expression of the papho" subunit and fully reconstituted respiratory burst activity. This suggests that the murine gp9lph0" subunit forms a functional cytochrome & heterodimer with human oxidase subunits, consistent with the high degree of identity between the mouse and human proteins in domains implicated in cytochrome function. 0 1996 by The American Society of Hematology.
As one approach to localize important functional domains within the gp9lphoX subunit of cytochrome b558, we have isolated a cDNA for the murine gp91Ph" using reverse transcriptase-polymerase chain reaction (RT-PCR). The encoded murine protein had 39 substitutions throughout the 570 amino acids compared with the human gp9lPbx polypeptide, many of which were conservative. Nonconserved substitutions occurred in regions outside of the putative heme, flavin, and NADPH binding domains. Expression of murine gp9lPh"* in a human myeloid cell line with a null gp9lPh" allele rescued expression of the protein and fully reconstituted respiratory burst activity in intact cells.
MATERIALS AND METHODS
PLB-985 cellsz4 and derivatives were maintained as de~cribed.'~ X-CGD PLB-985 cells were previously generated by targeted disruption of the gp9lPhUx gene, and lack endogenous gp9lPhU* and respiratory burst a~tivity.'~ For granulocyte differentiation, logarithmically growing PLB-985 and derivative cell lines at a density of 1 to 3 X lo5 cells/mL were exposed to 0.5% dimethylformamide (DMF) for 6 daysz5 Retrovirus packaging lines GP + Total RNA was extracted from mouse macrophage RAW cells using a guanidium thiocyanate protocol.2x First-strand cDNA was generated through reverse transcription with Moloney murine leukemia virus (M-MuLV) reverse transcriptase and random primers using the protocol supplied by the manufacturer (Boehringer Mannheim, Indianapolis, IN). Two synthetic oligonucleotide primers, derived from the human gp9Iph"I cDNA sequence, were prepared to attempt to amplify the murine gp9IPh'" cDNA using PCR: S-ACAATCTCG-AGACCATG GGG AAC TGG GCT GTG AAT GAA 6-3' (forward prim7and 5'-ACTTAGGATCCTTA GAA GTT TTC CTT GTT GAA AAT GAA GTG-3' (reverserimer). Sequences from the human gp9lPh'" cDNA are shown in bold and the initiator and the stop codons are underlined. The synthetic oligonucleotides also have additional nucleotides at their 5' end encoding Xho I and BumHI restriction sites, respectively. A full-length murine gp9 lph"* cDNA was obtained using Vent polymerase (New England Biolabs, Beverly, MA) to amplify the first-strand cDNA by PCR using the following temperature settings: 94°C x 1 minute, 65°C x I minute, 72°C X 3 % minutes, for a total of 35 cycles. The DNA fragment was purified using Magic PCR Preps DNA purification system (Promega, Madison, WI), digested with Xho I and BamHI, and subcloned into pBluescript I1 KS( +) (Stratagene, La Jolla, CA). Dideoxynucleotide sequencing was performed in both directions. Multiple clones from three independent amplifications were sequenced to ensure that the sequence obtained did not include PCR-induced mutations. Translation of the nucleotide sequence and best-fit alignments with the human gp91Ph"" sequencez9 were performed using the Genetics Computer Group molecular genetics software (Program Manual for the Wisconsin Package, Version 8; Genetics Computer Group, Madison, WI). The full-length murine gp91PhoX cDNA was subcloned into two different vectors after changing the 5' Xho I site to EcoRI: the mammalian expression vector pEF-PGKneoz' to generate the plasmid, pEFneom91, and the plasmid shuttle vector for the MSCVneoEB retrovirus3o to generate pMSCVneo-m91.
The MSCVneom91 plasmid was transfected into GP+E86 ecotropic packaging cells using DOTAP (Boehringer Mannheim). Transfected packaging cells were selected in G418 (GIBCO) at 0.8 mg/mL to isolate single colonies. To estimate a quantitative titer, 3T3 cells were infected as described3' and selected in (3418. Supernatant from a clone with the highest titer (1.5 X IO4 infectious particles/mL) was used to crossinfect GP + envAml2 amphotropic packaging cells ("ping-pong") to obtain amphotropic virus producer cells, m9lneoAml2. The total G418-resistant m9lneoAml2 cell population was used for subsequent transduction of X-CGD PLB-985 cells and had an estimated titer of -5 x lo3 infectious particles/mL as quantitated on 3T3 cells.
Introduction of gp91pho'. expression vectors into X-CGD PLB cells.
Between 1 and 2 x IO7 X-CGD PLB-985 cells in logarithmic growth were electroporated with the plasmid pEFneo-m91 and individual clones were isolated by limiting dilution in the presence of (3418, as previously described.z5 For infection with MSCVneo-m9 1 retrovirus, X-CGD PLB-985 cells were transduced by coculture with m9lneoAml2 amphotropic producer cells." After infection, cells were grown in the presence of (3418 to select for a population of transduced cells.
Total cellular RNA was isolated and analyzed by Northem blot as de~cribed.'~ RNA samples were probed with random prime-labeled full-length murine gp9Iph"" RT-PCR and subcloning of murine gp91Ph"' cDNA.
Construction of retrovirul producer cell lines.
RNA and immunoblot analysis. cDNA. Triton X-100 extracts and cellular membranes of nonadherent mouse bone marrow (BM) cells and of PLB-985 and derivative cells were prepared as previously described.25." Protein concentration was measured by BCA protein assay (Pierce, Rockford, 1L). On a per-cell basis, membrane extracts typically yield -20% to 35% of the protein obtained from whole-cell extracts. Immunoblot analysis was performed as describedz5 using either affinity-purified p22ph"' antibody or C-terminal antibody for gp9l""" as probes."
The nitroblue tetrazolium (NBT) assay was performed on granulocyte-induced PLB-985 cells or derivatives.*' For quantitative measurement of superoxide formation elicited by phorbol myristate acetate (PMA)-stimulated whole cells after granulocyte differentiation, the continuous cytochrome c assay was Assay ofsuperoxide formation.
RESULTS
To generate a full-length murine gp9lPh"' clone, synthetic oligonucleotide primers derived from the human gp9 lphor sequence were used to amplify the murine sequence from first-strand cDNA prepared from mouse macrophage mRNA.
A single -1,700-bp product was generated, whose nucleotide sequence was 87% identical to the human gp91rh"' cDNA* (not shown). The amino acid sequence of the encoded murine protein is shown in Fig 1, and is aligned with the human gp9 lph"x sequencez9 for comparison. The murine and human sequences are identical in 531 out of 570 amino acids, although note that the N-terminal 8 and C-terminal 9 amino acids in the murine sequence were specified by the oligonucleotide primers. Seventeen of the nonidentical amino acids represent conservative substitutions. Some of the residues that are dissimilar between the two species involve consensus sequences for N-linked glycosylation (N-X-S/T), with only two potential sites shared between the murine and human sequences (Fig 1) .
We investigated whether the murine gp91Ph"x protein could rescue ~2 2 "~~' expression and participate in superoxide generation in human X-CGD PLB-985 cells. Two different expression systems were used: a mammalian plasmid expression vector, pEF-PGKneo, in which the cDNA is under control of the human elongation-factor 1 -a promoter,25 and a retroviral vector, MSCVneoEB, in which cDNA expression is driven by a modified Maloney leukemia virus LTR." pEFneo-m91 was introduced into X-CGD PLB cells by electroporation, and stable transfectants isolated by limiting dilution. Twelve clones were randomly chosen for analysis, of which seven were NBT-positive, which demonstrated both successful transfection of the entire transgene as well as functional reconstitution of respiratory burst activity. On Northern blot analysis, NBT-negative clones lacked mRNA for gp91f'h0x (data not shown), which suggested that the transgene was nonfunctional in these cells. Four of the NBTpositive clones were chosen for further detailed analysis. Cell extracts were prepared from granulocyte-induced cells and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting to examine the expression of cytochrome b558 using antibodies for both g~9 1~~' '~ * The nucleotide sequence for the murine gp9IPh'" cDNA has been deposited in the Genbank database (accession no. U43384).
For and ~22"~"'. Untransfected X-CGD PLB-985 cells lack gp91ph"" and display markedly reduced levels of ~22"~"' (Fig  2A, lane 6 and Fig 2B, lane 5) . NBT-positive transfectants (Fig 2A, lanes 1 through 4) all expressed a protein of -58
kD that was immunoreactive with the gp9IPh"' antibody and which comigrated with the gp91ph"' species detected in nonadherent murine BM cells (of which -50% are neutrophils and -30% mononuclear phagocytes) (Fig 2A, lanes 7 and  8) . There was some clone-to-clone variation in the level of expression, which had previously been seen for expression of recombinant human gp9 Ip"'" using this vector.'' The relative level of recombinant murine gp9Ip""' was estimated to be 15% to 30% of that detected in murine BM cells. Murine gp91"""' was also expressed in X-CGD PLB-985 cells using a retroviral vector, MSCVneoEB. A (3418-resistant population was collected for analysis. Membrane extract was prepared from granulocyte-induced cells for immunoblot analysis of gp9lP""' expression (Fig 2A, lane 5) . which was comparable to that seen using the pEFneo-m91 vector. Finally, expression of recombinant murine gp91p""' resulted in markedly increased levels of the ~22"""' subunit in human X-CGD cells, as assessed by immunoblotting (Fig 2B) . A continuous cytochrome c reduction assay was used to quantitate respiratory burst activity in granulocyte-induced X-CGD PLB-985 cells that expressed recombinant murine gp9Ip""' ( Table I) For PLB-985 cell lines were induced to differentiate with 0.5% DMF for 6 days. Superoxide generation in PMA-stimulated whole cells was measured by a continuous cytochrome c reduction assay. Data for superoxide formation are the mean 2 SD, and there were no statistical differences between wild-type PLB-985 cells and the pEFneo-m91-transfected clones expressing murine gp9IPhox, using the unpaired t-test.
gp9lpbX restored respiratory burst activity to wild-type range, with no significant difference in either the maximal rate or total amount of superoxide produced over 30 minutes. In addition, no difference in the overall kinetics of superoxide generation were noted in the hybrid mouse-human system (not shown).
DISCUSSION
The phagocyte flavocytochrome b558 heterodimer functions as the redox center of the respiratory burst oxidase, mediating the transfer of electrons from NADPH to oxygen upon translocation of cytosolic oxidase subunits to the plasma membrane. Although the relative functions of each subunit have not been fully defined, current data suggest that each subunit contains a heme center and that both flavin and NADPH binding sites are localized to gp91ph"x.2~10~'5 Th e human gp91Ph" polypeptide has 570 amino acid residues, and contains multiple hydrophobic domains in addition to five potential N-linked glycosylation sites29 (Fig 1) . No polymorphisms have been reported for the human sequence and all identified amino acid substitutions have been associated with X-linked CGD, suggesting that there are stringent requirements in the primary sequence to preserve structure and/or function. ' Here we report cloning of a cDNA encoding the murine gp91PhoX subunit by RT-PCR, using oligonucleotide primers derived from the human sequence. The predicted murine and human gp91ph" protein sequences differ by only 39 out of 570 amino acids (93% identity) (Fig 1) . Positions where amino acid substitutions have been identified in X-CGD patients are all conserved in the murine gp91Ph" protein. ' Amino acids that are not conserved between the human and murine polypeptides are largely localized to hydrophilic regions of the polypeptide, including several substitutions that alter potential N-glycosylation sites (Fig 1) . The murine gp9lpbx protein contains four potential N-linked glycosylation sites, of which the two most carboxyl-terminal lie in what is most likely an intracytoplasmic d~m a i n .~~.~~ Utilization of fewer N-linked glycosylation sites is likely to explain why the murine gp91PhoX migrates with an apparent molecular mass of -58 kD, compared with -91 kD for the human protein. Upon deglycosylation, the murine and human core proteins both migrate at -54 kD. 32 The C-terminal sequences of gp91Ph" suggested to form the NADPH binding site are all conserved in the murine sequence (Fig 1) . Specific residues involved in flavin binding are less clear, but are believed to reside within residues 290 through 390. This region is identical in the mouse and human gp91Ph'" sequences. There are only two nonconservative substitutions within hydrophobic domains of the mouse and human proteins. Some or all of these regions are likely to be transmembrane or intramembranous domains in which the heme prosthetic groups are embedded. Raman and electron paramagnetic resonance spectroscopy have suggested that the hemes are coordinated with imidazole or imidazolate ligands supplied by histidine residues."' All histidines are conserved between the murine and human sequences (Fig  1) . Finally, several regions within gp91Ph"' that may interact with (residues 86 through 93 and 450 through 457)'' are conserved between the mouse and human gp9Iph'" proteins. The degree of similarity in a carboxy-terminal terminal sequence of gp91Ph0" (residues 559 through 565), also implicated as a binding site for p47ph"x,34 cannot be because most of this region of the murine sequence was derived from the reverse PCR primer.
In the studies reported here, the murine gp91Ph" was capable of both rescuing stable expression of human ~2 2~~" and of complementing other human oxidase subunits to fully reconstitute respiratory burst activity in human X-CGD cells. These observations strongly suggest that a functional heterodimeric complex is formed between murine gp9lPh'" and human ~2 2~~" subunits. Moreover, the kinetics of superoxide formation were indistinguishable from wild-type human PLB-985 cells, suggesting that the assembly of the multisubunit active oxidase complex is unaffected. These observations are consistent with the conservation of sequences between human and murine gp9Iph"" in domains likely to be involved in redox function and oxidase assembly. These results also underscore the high degree of cross-species conservation in the NADPH oxidase complex.
Other studies have also suggested that NADPH oxidase subunits from different species have a high degree of similarity in both amino acid sequence and function. Comparisons of porcine and human ~2 2~~"~ showed 83% amino acid similarity, and of murine and human ~2 2 "~" revealed 88% protein id en tit^.",'^ Murine and human ~4 7~~" " have 82% amino acid identity.38 Antihuman antisera to the cytochrome bs58 components cross-react with the guinea pig cytochrome subunits in immunobl~ts.'~ Heterologous cell-free oxidase assays have demonstrated functional cross-species complementation between human B-cell cytosolic factors and bovine membranes, rabbit membranes, and bovine cytosolic factors, and murine p47ph"* combined with human oxidase s~bunits.''.~".~'
Allogeneic BM transplantation has successfully been used to treat some individuals with CGD and somatic gene therapy is a potential treatment option in the future.42 MSCV retroviral vectors have been shown to exhibit long-term ex- 
